Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jun 03, 2026
Why Is International Business Machines (IBM) Stock Down -5% Today?

Why Is International Business Machines (IBM) Stock Down -5% Today?

Key Takeaways

  • IBM shares are declining approximately 5% in Wednesday's session, pulling back from a prior close of $320.42
  • The primary driver is profit-taking after an extraordinary two-week rally that saw shares surge more than 25%, fueled by a $10 billion quantum computing investment and a bullish Barclays initiation at Overweight with a $350 price target
  • Broader risk-off sentiment is adding pressure, with the ISM Non-Manufacturing data released this morning contributing to macro uncertainty
  • The technology and software sector continues to face valuation headwinds in 2026, and IBM's recent sharp run-up left the stock technically extended
  • Traders are watching whether IBM can hold recent breakout levels and whether the quantum computing narrative maintains its momentum heading into Q2 2026 earnings

Opening Summary

International Business Machines Corporation (IBM) is a global technology and consulting leader offering hybrid cloud platforms, artificial intelligence solutions, quantum computing infrastructure, and enterprise IT services. Shares are trading down roughly 5% on Wednesday, June 3, 2026, moving from a prior session close of $320.42 toward the $306–$307 range. The decline follows a spectacular late-May rally in which IBM surged more than 25% in just over a week — a run that appears to be triggering a healthy round of profit-taking as traders lock in gains from one of the sharpest short-term rallies in the stock's recent history.

Profit-Taking After a Historic Rally

The immediate driver behind today's price decline is straightforward: IBM ran too far, too fast. On May 29, shares jumped 12.6% in a single session after the company announced a $10 billion, five-year commitment to quantum computing backed by the CHIPS Act. That momentum carried into June 1, when Barclays initiated coverage with an Overweight rating and a $350 price target, sending shares up another 10% and pushing IBM to its highest level in over a year. After gaining roughly 25% in fewer than five trading days, profit-taking pressure was all but inevitable — investors who bought on weakness throughout 2026 are now exiting with strong gains.

Quantum Catalyst Fades, Valuation Concerns Return

While the quantum computing announcement and Barclays initiation were powerful short-term catalysts, investors are now stepping back to assess whether IBM's fundamentals justify the elevated price level. The stock had spent most of 2026 as a notable laggard among mega-cap technology names, shedding as much as 25% year-to-date at its trough in mid-May. The rapid re-rating raises legitimate questions: the $10 billion quantum commitment spans five years and will not immediately translate into revenue, while IBM's Q1 2026 results — which beat estimates — were still met with selling as investors found the margin of outperformance underwhelming. The market is now recalibrating between the long-term quantum narrative and the near-term reality of slowing consulting and software growth.

Macro Pressures and Sector Headwinds

Beyond company-specific dynamics, today's session is unfolding against a cautious macro backdrop. ISM Non-Manufacturing data released this morning is contributing to uncertainty about the pace of U.S. economic activity, a key concern for enterprise software and consulting firms like IBM that rely on corporate IT spending. The broader technology sector has faced persistent valuation compression throughout 2026, with growth names penalized by rate sensitivity and concerns over the long-term impact of generative AI on legacy IT services business models. Peer AI-facing technology stocks are showing mixed performance Wednesday, reflecting the sector-wide caution.

Market Context and Trading Activity

Today's volume is elevated relative to IBM's 65-day average of approximately 4.69 million shares, consistent with active institutional repositioning following the late-May surge. The stock opened at $313.75 and has extended losses through the morning session. From a technical standpoint, the sharp pullback is occurring after IBM broke above its 52-week high near $332 in recent sessions — a level that often attracts short-sellers and profit-takers simultaneously. The broader Dow Jones Industrial Average, of which IBM is a component, is also under mild pressure, though IBM's decline is outpacing the index, indicating stock-specific dynamics are the dominant force.

Trending AI Robots

For active traders navigating volatile sessions like today's, Tickeron's Trending AI Robots page provides a curated window into the platform's highest-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI-powered bots covering thousands of tickers across equities, ETFs, and sectors — but the Trending AI Robots section highlights only those bots demonstrating the strongest live performance metrics at any given time. Each bot differs by strategy type (momentum, mean reversion, breakout), trading timeframe, risk profile, and the specific instruments it trades, allowing users to match tools to their own approach. Whether you are trading large-cap tech names or navigating sector rotations, exploring the trending bots can offer a data-driven advantage in fast-moving markets.

What Comes Next for IBM

The next major catalyst for IBM is its Q2 2026 earnings report, which will provide critical insight into whether the quantum computing investment has begun driving incremental revenue or bookings, and whether consulting and software segments are recovering from earlier weakness in the year. Analysts currently hold a consensus Buy rating on the stock, with Wall Street closely monitoring the pace of Confluent integration following IBM's acquisition and RedHat's growth trajectory in a competitive hybrid cloud market. Key risks include a broader tech sector de-rating, continued pressure on enterprise IT spending budgets, and the possibility that the quantum computing narrative — however compelling long-term — struggles to sustain near-term price momentum without tangible revenue updates. On the upside, IBM's deepening partnership with Nvidia across cloud services, enterprise hardware, and data storage infrastructure represents a credible long-term growth angle that analysts continue to evaluate.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: IBM

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Momentum Indicator for IBM turns positive, indicating new upward trend

IBM saw its Momentum Indicator move above the 0 level on August 19, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 78 similar instances where the indicator turned positive. In of the 78 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IBM's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IBM just turned positive on July 31, 2026. Looking at past instances where IBM's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in of 372 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 263 cases where IBM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where IBM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 10-day moving average for IBM crossed bearishly below the 50-day moving average on July 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.443) is normal, around the industry mean (7.110). P/E Ratio (20.931) is within average values for comparable stocks, (70.841). IBM's Projected Growth (PEG Ratio) (2.408) is slightly higher than the industry average of (1.226). Dividend Yield (0.029) settles around the average of (0.025) among similar stocks. P/S Ratio (3.246) is also within normal values, averaging (147.745).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IBM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 9.37B. The market cap for tickers in the group ranges from 0 to 222.04B. IBM holds the highest valuation in this group at 222.04B. The lowest valued company is ARSC at 0.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was 0%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 19%. JFU experienced the highest price growth at 30%, while WYFI experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was 6%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was -21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 63
Price Growth Rating: 57
SMR Rating: 72
Profit Risk Rating: 93
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
IBM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of various computer products through the use of advanced information technology

Industry InformationTechnologyServices

Profile
Details
Industry
Information Technology Services
Address
One New Orchard Road
Phone
+1 914 499-1900
Employees
305300
Web
http://www.ibm.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.